Establishment Labs

Establishment Labs Holdings inaugurated its Sulàyöm innovation and manufacturing campus in Zona Franca Coyol, Alajuela, Costa Rica, with a $45 million investment. The 9,300 m² facility doubles manufacturing capacity for breast implants and will create 1,000 jobs.

Establishment Labs Holdings Inc. held the groundbreaking ceremony for its new Sulayöm Innovation Campus in Costa Rica. The 145,000-square-foot facility will more than double annual manufacturing capacity to approximately 1,900,000 Motiva implants and add R&D, digital media, training, and medical education capabilities.

Establishment Labs, a medical device company focused on breast surgery technologies, closed an $18 million financing round with participation from Kilowatt Capital and Florence Capital Advisors. The funds will support the launch of Motiva Implants and Puregraft in global markets.

Establishment Labs opened a new silicone medical device manufacturing facility in Costa Rica, with an investment of $16.5 million. Commercial-scale production is scheduled to begin by early 2017.

Establishment Labs, a Costa Rican breast implant manufacturer, is investing $35 million to expand its global operations. Of this, $16.5 million will go to a new mammary implant manufacturing plant in the Coyol Free Zone in Alajuela, Costa Rica.